4Bear HD, Anderson S, Smith RE, et al. A randomized trial comparing preoperative (preop) doxorubiein/eyelophosphamide (AC) to preop AC followed by preop doeetaxel (T) and to preop AC followed by postoperative(postop) T in patients(pts) with operable carcinoma of the breast ;results of NSABP B-27 [ J]. Breast Cancer Res Treat, 2004,88(Suppl 1 ) :16.
5Chan S, Friedriehs K, Noel D, et al. Prospective randomized trial of doeetaxel versus doxorubiein in patients with metastatic breast cancer [J]. JClinOneol, 1999, 17(8):2341-2354.
6周际昌.实用肿瘤内科学[M].2版.北京:人民卫生出版社,1998:343-345.
7Watatani M, Ueda K, Daito K, et al. Clinical experience of weekly paclitaxel-based treatment as preoperative chemotherapy for patients with primary breast cancer [ J ]. Breast Cancer, 2004,11 ( 2 ) : 187 - 193.
8Green MC, Buzdar AU, Smith T, et al. Weekly paelitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks[ J]. J Clin Oncol, 2005,23 (25) : 5983-5992.
9Marchetti P, Urien S, Cappellini GA, et al. Weekly administration of paelitaxel: theoretical and clinical basis [ J ]. Crit Rev Oneol Hematol, 2002, 44 Suppl:S3 -13.
10Mey U, Gorsehluter M, Ziske C, et al. Weekly doeetaxel in patients with pretreated metastatic breast cancer, a phase Ⅱ trial[ J]. Anticancer Drugs, 2003,14(3) : 233 -238.
